The potential role of nanomedicine on COVID-19 therapeutics.
作者信息
Mainardes Rubiana Mara, Diedrich Camila
机构信息
Pharmaceutical Nanotechnology Laboratory, Universidade Estadual do Centro-Oeste, Alameda Élio Antonio Dalla Vecchia, 838 - CEP, Guarapuava PR 85040-167, Brazil.
出版信息
Ther Deliv. 2020 Jul;11(7):411-414. doi: 10.4155/tde-2020-0069. Epub 2020 Jun 29.
Abstract
摘要
相似文献
1
The potential role of nanomedicine on COVID-19 therapeutics.纳米医学在新冠病毒治疗中的潜在作用。
Ther Deliv. 2020 Jul;11(7):411-414. doi: 10.4155/tde-2020-0069. Epub 2020 Jun 29.
2
Dexamethasone nanomedicines for COVID-19.用于治疗新冠肺炎的地塞米松纳米药物。
Nat Nanotechnol. 2020 Aug;15(8):622-624. doi: 10.1038/s41565-020-0752-z.
3
Novel approach for low-dose pulmonary delivery of hydroxychloroquine in COVID-19.新型冠状病毒肺炎中羟氯喹低剂量肺部给药的新方法。
Br J Pharmacol. 2020 Nov;177(21):4997-4998. doi: 10.1111/bph.15167. Epub 2020 Jul 13.
4
Databases for the targeted COVID-19 therapeutics.针对新型冠状病毒肺炎的治疗药物数据库。
Br J Pharmacol. 2020 Nov;177(21):4999-5001. doi: 10.1111/bph.15234. Epub 2020 Sep 28.
5
Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).关于氯喹/羟氯喹治疗 2019 年冠状病毒病（COVID-19）的最新情况。
Biosci Trends. 2020 May 21;14(2):156-158. doi: 10.5582/bst.2020.03072. Epub 2020 Apr 13.
6
Does hydroxychloroquine combat COVID-19? A timeline of evidence.羟氯喹能对抗新冠病毒吗？证据时间表。
J Am Acad Dermatol. 2020 Jul;83(1):e33-e34. doi: 10.1016/j.jaad.2020.04.031. Epub 2020 Apr 10.
7
The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing.新冠疫情全球解决方案X奖以及对可扩展、快速且广泛检测的需求。
Nat Biotechnol. 2020 Sep;38(9):1021-1024. doi: 10.1038/s41587-020-0655-4.
8
BET 2: Hydroxychloroquine in the treatment of COVID-19.BET 2：羟氯喹治疗2019冠状病毒病
Emerg Med J. 2020 Jul;37(7):451-453. doi: 10.1136/emermed-2020-210221.3.
9
Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic.环境因素对针对新冠疫情生成计算定义的天然分子的重要性。
Curr Top Med Chem. 2020;20(22):1958-1961. doi: 10.2174/156802662022200917110430.
10
COVID-19 in Pediatrics: A Laboratory Perspective.儿科中的新型冠状病毒肺炎：实验室视角
J Appl Lab Med. 2020 Jul 1;5(4):824-828. doi: 10.1093/jalm/jfaa065.
引用本文的文献
1
State-of-art high-performance Nano-systems for mutated coronavirus infection management: From Lab to Clinic.用于突变型冠状病毒感染管理的前沿高性能纳米系统：从实验室到临床。
OpenNano. 2022 Nov-Dec;8:100078. doi: 10.1016/j.onano.2022.100078. Epub 2022 Sep 10.
2
Nanomedicine for the Treatment of Viral Diseases: Smaller Solution to Bigger Problems.用于治疗病毒性疾病的纳米医学：解决大问题的更小方案。
Pharmaceutics. 2024 Mar 16;16(3):407. doi: 10.3390/pharmaceutics16030407.
3
Emerging Applications of Nanotechnology in Healthcare and Medicine.纳米技术在医疗保健和医学中的新兴应用。
Molecules. 2023 Sep 14;28(18):6624. doi: 10.3390/molecules28186624.
4
Nano-Enabled Antivirals for Overcoming Antibody Escaped Mutations Based SARS-CoV-2 Waves.基于纳米技术的抗病毒药物可克服基于 SARS-CoV-2 的抗体逃逸突变波。
Int J Mol Sci. 2023 Aug 23;24(17):13130. doi: 10.3390/ijms241713130.
5
An update on vaccine status and the role of nanomedicine against SARS-CoV-2: A narrative review.疫苗现状及纳米医学在对抗新型冠状病毒方面的作用的最新进展：一篇叙述性综述。
Health Sci Rep. 2023 Jul 2;6(7):e1377. doi: 10.1002/hsr2.1377. eCollection 2023 Jul.
6
Current Trends and Prospects for Application of Green Synthesized Metal Nanoparticles in Cancer and COVID-19 Therapies.绿色合成金属纳米粒子在癌症和 COVID-19 治疗中的应用现状及展望。
Viruses. 2023 Mar 13;15(3):741. doi: 10.3390/v15030741.
7
Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications.用于新冠疫苗开发的纳米技术及其递送应用的各个方面。
Pharmaceutics. 2023 Jan 30;15(2):451. doi: 10.3390/pharmaceutics15020451.
8
Nanoparticles: Taking a Unique Position in Medicine.纳米颗粒：在医学领域占据独特地位。
Nanomaterials (Basel). 2023 Jan 31;13(3):574. doi: 10.3390/nano13030574.
9
Nanoparticles in clinical trials of COVID-19: An update.COVID-19 临床试验中的纳米颗粒：最新进展。
Int J Surg. 2022 Aug;104:106818. doi: 10.1016/j.ijsu.2022.106818. Epub 2022 Aug 8.
10
A systemic review on liquid crystals, nanoformulations and its application for detection and treatment of SARS - CoV- 2 (COVID - 19).关于液晶、纳米制剂及其在严重急性呼吸综合征冠状病毒2（SARS-CoV-2，即新冠病毒）检测与治疗中的应用的系统评价。
J Mol Liq. 2022 Sep 15;362:119795. doi: 10.1016/j.molliq.2022.119795. Epub 2022 Jul 8.
本文引用的文献
1
Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?为什么纳米技术在全球对抗冠状病毒大流行的斗争中没有得到充分利用？
Nanomedicine (Lond). 2020 Jul;15(17):1719-1734. doi: 10.2217/nnm-2020-0163. Epub 2020 May 28.
2
The current understanding and potential therapeutic options to combat COVID-19.当前对抗 COVID-19 的理解和潜在治疗选择。
Life Sci. 2020 Aug 1;254:117765. doi: 10.1016/j.lfs.2020.117765. Epub 2020 May 8.
3
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.新型冠状病毒肺炎感染：人类冠状病毒的起源、传播及特征
J Adv Res. 2020 Mar 16;24:91-98. doi: 10.1016/j.jare.2020.03.005. eCollection 2020 Jul.
4
Coronavirus disease 2019 (COVID-19): current status and future perspectives.新型冠状病毒病 2019（COVID-19）：现状和未来展望。
Int J Antimicrob Agents. 2020 May;55(5):105951. doi: 10.1016/j.ijantimicag.2020.105951. Epub 2020 Mar 29.
5
COVID-19, SARS and MERS: are they closely related?新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征：它们有何关联？
Clin Microbiol Infect. 2020 Jun;26(6):729-734. doi: 10.1016/j.cmi.2020.03.026. Epub 2020 Mar 28.
6
Race to find COVID-19 treatments accelerates.寻找新冠病毒治疗方法的竞赛加速。
Science. 2020 Mar 27;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412.
7
The Battle Against COVID-19: Where Do We Stand Now?抗击新冠疫情：我们目前的进展如何？
Iran J Med Sci. 2020 Mar;45(2):81-82. doi: 10.30476/ijms.2020.46357.
8
Insights from nanomedicine into chloroquine efficacy against COVID-19.纳米医学对氯喹治疗 COVID-19 疗效的启示。
Nat Nanotechnol. 2020 Apr;15(4):247-249. doi: 10.1038/s41565-020-0674-9.
9
Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence.基于现有证据对 2019 年新型冠状病毒（SARS-CoV-2）的回顾。
Int J Antimicrob Agents. 2020 Jun;55(6):105948. doi: 10.1016/j.ijantimicag.2020.105948. Epub 2020 Mar 19.
10
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎的临床、实验室和影像学特征：系统评价和荟萃分析。
Travel Med Infect Dis. 2020 Mar-Apr;34:101623. doi: 10.1016/j.tmaid.2020.101623. Epub 2020 Mar 13.
Zotero 插件